drugset / Trial / NCT04083430

Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D Vaccination

NCT04083430

Phase 4 Unknown 60 enrolled University of Aarhus
NaSingle-groupOpen-labelBasic science

Summary

Investigating cytotoxicity of yellow fever specific CD8 T cells following YF-17D vaccination and the following licensing of these epitope-specific CD8 T cells

Timeline

Start
2019-10-08
Primary completion
2025-02-15
Completion
2025-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Yellow Fever Vaccine Vaccine 0.5 ml Other

Indications